靶向IKK和IKK相关激酶用于癌症治疗的研究进展。
Advances in targeting IKK and IKK-related kinases for cancer therapy.
作者信息
Lee Dung-Fang, Hung Mien-Chie
机构信息
Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
出版信息
Clin Cancer Res. 2008 Sep 15;14(18):5656-62. doi: 10.1158/1078-0432.CCR-08-0123.
Abstract
IkappaB kinases (IKK) and IKK-related kinases play critical roles in regulating the immune response through nuclear factor-kappaB and IFN regulatory factor-dependent signaling transduction cascades. Recently, these kinases have been implicated in the pathogenesis of many human diseases, including cancer. In fact, dysregulation of IKK activities promotes tumor survival, proliferation, migration, metastasis, and angiogenesis-common characteristics of many types of human cancers. Because of their oncogenic effects in human cancer development, targeting IKK and IKK-related kinases is becoming an increasingly popular avenue for the development of novel therapeutic interventions for cancer. This review will briefly cover the recent discovery of the downstream substrates of IKK and IKK-related kinases, and outline the strategies used for targeting IKK as a therapeutic intervention for cancer.
摘要
IκB激酶（IKK）及IKK相关激酶通过核因子-κB和干扰素调节因子依赖性信号转导级联反应在调节免疫应答中发挥关键作用。最近，这些激酶与包括癌症在内的多种人类疾病的发病机制有关。事实上，IKK活性失调会促进肿瘤存活、增殖、迁移、转移及血管生成，这些都是多种人类癌症的共同特征。由于它们在人类癌症发展中的致癌作用，靶向IKK及IKK相关激酶正日益成为开发新型癌症治疗干预措施的热门途径。本综述将简要介绍IKK及IKK相关激酶下游底物的最新发现，并概述将靶向IKK作为癌症治疗干预措施所采用的策略。
相似文献
1
Advances in targeting IKK and IKK-related kinases for cancer therapy.靶向IKK和IKK相关激酶用于癌症治疗的研究进展。
Clin Cancer Res. 2008 Sep 15;14(18):5656-62. doi: 10.1158/1078-0432.CCR-08-0123.
2
Targeting IκappaB kinases for cancer therapy.针对 IκappaB 激酶的癌症治疗。
Semin Cancer Biol. 2019 Jun;56:12-24. doi: 10.1016/j.semcancer.2018.02.007. Epub 2018 Feb 24.
3
Regulation and function of IKK and IKK-related kinases.IKK及IKK相关激酶的调控与功能
Sci STKE. 2006 Oct 17;2006(357):re13. doi: 10.1126/stke.3572006re13.
4
17-Acetoxyjolkinolide B irreversibly inhibits IkappaB kinase and induces apoptosis of tumor cells.17-乙酰氧基乔可瑞内酯B不可逆地抑制IκB激酶并诱导肿瘤细胞凋亡。
Mol Cancer Ther. 2008 Jun;7(6):1523-32. doi: 10.1158/1535-7163.MCT-08-0263.
5
Role of IkappaB kinase in tumorigenesis.IκB激酶在肿瘤发生中的作用。
Future Oncol. 2005 Feb;1(1):67-78. doi: 10.1517/14796694.1.1.67.
6
A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models.一种新型、高度选择性、紧密结合的IκB激酶-2（IKK-2）抑制剂：一种将IKK-2活性与关节炎相关细胞和动物模型中核因子-κB信号通路各组分的命运和功能相关联的工具。
J Pharmacol Exp Ther. 2009 Apr;329(1):14-25. doi: 10.1124/jpet.108.143800. Epub 2009 Jan 23.
7
Small-molecule inhibitors of IκB kinase (IKK) and IKK-related kinases.IκB激酶（IKK）及IKK相关激酶的小分子抑制剂
Pharm Pat Anal. 2013 Jul;2(4):481-98. doi: 10.4155/ppa.13.31.
8
Targeting IKK and NF-κB for Therapy.以IKK和NF-κB为靶点进行治疗。
Adv Protein Chem Struct Biol. 2017;107:77-115. doi: 10.1016/bs.apcsb.2016.11.006. Epub 2017 Jan 11.
9
IKK biology.IKK 生物学。
Immunol Rev. 2012 Mar;246(1):239-53. doi: 10.1111/j.1600-065X.2012.01107.x.
10
Protein Kinase-Mediated Decision Between the Life and Death.蛋白激酶介导的生死抉择。
Adv Exp Med Biol. 2021;1275:1-33. doi: 10.1007/978-3-030-49844-3_1.
引用本文的文献
1
Yiqi Wenyang decoction protects against the development of atherosclerosis by inhibiting vascular inflammation.益气温阳汤通过抑制血管炎症来预防动脉粥样硬化的发展。
Pharm Biol. 2025 Dec;63(1):264-274. doi: 10.1080/13880209.2025.2492650. Epub 2025 Apr 20.
2
Interplay of Cellular Nrf2/NF-κB Signalling after Plasma Stimulation of Malignant vs. Non-Malignant Dermal Cells.恶性与非恶性皮肤细胞经血浆刺激后的细胞 Nrf2/NF-κB 信号相互作用。
Int J Mol Sci. 2024 Oct 11;25(20):10967. doi: 10.3390/ijms252010967.
3
Repurposing of known drugs for COVID-19 using molecular docking and simulation analysis.利用分子对接和模拟分析将已知药物用于治疗新冠肺炎
Bioinformation. 2023 Feb 28;19(2):149-159. doi: 10.6026/97320630019149. eCollection 2023.
4
Involvement of the AKT Pathway in Resistance to Erlotinib and Cabozantinib in Triple-Negative Breast Cancer Cell Lines.AKT信号通路在三阴性乳腺癌细胞系对厄洛替尼和卡博替尼耐药中的作用
Biomedicines. 2023 Aug 28;11(9):2406. doi: 10.3390/biomedicines11092406.
5
IκB kinase β (IKKβ): Structure, transduction mechanism, biological function, and discovery of its inhibitors.IKKβ（IκB 激酶 β）：结构、转导机制、生物学功能及其抑制剂的发现。
Int J Biol Sci. 2023 Aug 6;19(13):4181-4203. doi: 10.7150/ijbs.85158. eCollection 2023.
6
Identification of 1-pyrazolo[3,4-b]pyridine derivatives as novel and potent TBK1 inhibitors: design, synthesis, biological evaluation, and molecular docking study.鉴定 1-吡唑并[3,4-b]吡啶衍生物为新型强效 TBK1 抑制剂：设计、合成、生物评价及分子对接研究。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):1411-1425. doi: 10.1080/14756366.2022.2076674.
7
Targeting IKKα kinase to prevent tumor progression and therapy resistance.靶向IKKα激酶以预防肿瘤进展和治疗耐药性。
Cancer Drug Resist. 2020 Mar 21;3(3):482-490. doi: 10.20517/cdr.2019.104. eCollection 2020.
8
IKK mediates homeostatic function in inflammation competitively phosphorylating AMPK and IB.IKK 通过竞争性磷酸化 AMPK 和 IκB 在炎症中发挥稳态功能。
Acta Pharm Sin B. 2022 Feb;12(2):651-664. doi: 10.1016/j.apsb.2021.09.012. Epub 2021 Sep 17.
9
The Synergy of ADAM17-Induced Myocardial Inflammation and Metabolic Lipids Dysregulation During Acute Stress: New Pathophysiologic Insights Into Takotsubo Cardiomyopathy.急性应激期间ADAM17诱导的心肌炎症与代谢性脂质失调的协同作用：对应激性心肌病的新病理生理学见解
Front Cardiovasc Med. 2021 Jun 4;8:696413. doi: 10.3389/fcvm.2021.696413. eCollection 2021.
10
Targeting AGTR1/NF-κB/CXCR4 axis by miR-155 attenuates oncogenesis in glioblastoma.靶向 AGTR1/NF-κB/CXCR4 轴的 miR-155 抑制胶质母细胞瘤的发生。
Neoplasia. 2020 Oct;22(10):497-510. doi: 10.1016/j.neo.2020.08.002. Epub 2020 Sep 5.
本文引用的文献
1
All roads lead to mTOR: integrating inflammation and tumor angiogenesis.条条大路通mTOR：整合炎症与肿瘤血管生成
Cell Cycle. 2007 Dec 15;6(24):3011-4. doi: 10.4161/cc.6.24.5085. Epub 2007 Sep 20.
2
IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway.IKKβ对TSC1的抑制作用通过mTOR途径连接炎症与肿瘤血管生成。
Cell. 2007 Aug 10;130(3):440-55. doi: 10.1016/j.cell.2007.05.058.
3
Integrative genomic approaches identify IKBKE as a breast cancer oncogene.整合基因组学方法确定IKBKE为一种乳腺癌致癌基因。
Cell. 2007 Jun 15;129(6):1065-79. doi: 10.1016/j.cell.2007.03.052.
4
The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis.化疗药物DMXAA能有效且特异性地激活TBK1-IRF-3信号轴。
J Exp Med. 2007 Jul 9;204(7):1559-69. doi: 10.1084/jem.20061845. Epub 2007 Jun 11.
5
Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB.IKKα对CBP的磷酸化作用通过将CBP的结合偏好从p53转换为NF-κB来促进细胞生长。
Mol Cell. 2007 Apr 13;26(1):75-87. doi: 10.1016/j.molcel.2007.02.019.
6
Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin.核因子激活的IKKα通过抑制Maspin来控制前列腺癌转移。
Nature. 2007 Apr 5;446(7136):690-4. doi: 10.1038/nature05656. Epub 2007 Mar 18.
7
Integrating cell-signalling pathways with NF-kappaB and IKK function.整合细胞信号通路与核因子-κB及IκB激酶功能
Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62. doi: 10.1038/nrm2083.
8
Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression.核因子-κB与κB激酶抑制因子通路在肿瘤发生起始及进展过程中的作用
Oncogene. 2006 Oct 30;25(51):6817-30. doi: 10.1038/sj.onc.1209942.
9
Regulation and function of IKK and IKK-related kinases.IKK及IKK相关激酶的调控与功能
Sci STKE. 2006 Oct 17;2006(357):re13. doi: 10.1126/stke.3572006re13.
10
RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival.RalB GTP酶介导的IkappaB家族激酶TBK1激活将先天免疫信号与肿瘤细胞存活联系起来。
Cell. 2006 Oct 6;127(1):157-70. doi: 10.1016/j.cell.2006.08.034.
Zotero 插件